neostigmine has been researched along with Hemorrhage, Subarachnoid in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, F | 1 |
| Saand, A | 1 |
| Xing, C | 1 |
| Lee, JW | 1 |
| Hsu, L | 1 |
| Palmer, OP | 1 |
| Jackson, V | 1 |
| Tang, L | 1 |
| Ning, M | 1 |
| Du, R | 1 |
| Kochanek, PM | 1 |
| Lo, EH | 1 |
| Chou, SH | 1 |
1 other study available for neostigmine and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
CSF lipocalin-2 increases early in subarachnoid hemorrhage are associated with neuroinflammation and unfavorable outcome.
Topics: Aged; Cerebrospinal Fluid; Female; Humans; Inflammation; Lipocalin-2; Male; Middle Aged; Neostigmine | 2021 |